Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy

Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy

This review discusses various issues to consider when developing standard operating procedures for pre-clinical studies in the mdx mouse model of Duchenne muscular dystrophy (DMD). The review describes and evaluates a wide range of techniques used to measure parameters of muscle pathology in mdx mic...

Full description

Bibliographic Details
Main Authors:	Miranda D. Grounds, Hannah G. Radley, Gordon S. Lynch, Kanneboyina Nagaraju, Annamaria De Luca
Format:	Article
Language:	English
Published:	Elsevier 2008-07-01
Series:	Neurobiology of Disease
Subjects:	Mdx mouse Muscular dystrophy Standard operating procedures Biological variation Muscle function Pre-clinical trials
Online Access:	http://www.sciencedirect.com/science/article/pii/S096999610800065X

Similar Items

Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy
by: Brigida Boccanegra, et al.
Published: (2023-04-01)

Importância do camundongo mdx na fisiopatologia da distrofia muscular de Duchenne The importance of mdx mouse in the pathophysiology of Duchenne's muscular distrophy
by: Sandra Lopes Seixas, et al.
Published: (1997-09-01)

Expression and function of four AAV-based constructs for dystrophin restoration in the mdx mouse model of Duchenne muscular dystrophy
by: Rachael A. Potter, et al.
Published: (2023-09-01)

A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle
by: Basma A. Al-Mshhdani, et al.
Published: (2021-08-01)

In vivo cerebellar circuit function is disrupted in an mdx mouse model of Duchenne muscular dystrophy
by: Trace L. Stay, et al.
Published: (2020-02-01)

Trained immunity as a potential target for therapeutic immunomodulation in Duchenne muscular dystrophy
by: Basil J. Petrof, et al.
Published: (2023-06-01)

Dystrophin Is Required for the Proper Timing in Retinal Histogenesis: A Thorough Investigation on the mdx Mouse Model of Duchenne Muscular Dystrophy
by: Irene Persiconi, et al.
Published: (2020-08-01)

Functional cardiac consequences of β-adrenergic stress-induced injury in a model of Duchenne muscular dystrophy
by: Conner C. Earl, et al.
Published: (2024-10-01)

The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy
by: Caroline Merckx, et al.
Published: (2022-02-01)

Respiratory performance in Duchenne muscular dystrophy: Clinical manifestations and lessons from animal models
by: Rebecca Delaney, et al.
Published: (2024-09-01)

Long‐term human IgG treatment improves heart and muscle function in a mouse model of Duchenne muscular dystrophy
by: Jana Zschüntzsch, et al.
Published: (2020-08-01)

Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy
by: Lukasz Bozycki, et al.
Published: (2018-07-01)

The Effect of Vitamin D Supplementation on Skeletal Muscle in the <i>mdx</i> Mouse Model of Duchenne Muscular Dystrophy
by: Danielle A. Debruin, et al.
Published: (2019-04-01)

The new challenge of “exercise + X″ therapy for Duchenne muscular dystrophy—Individualized identification of exercise tolerance and precise implementation of exercise intervention
by: Yuhui Su, et al.
Published: (2022-08-01)

What Nutraceuticals Can Do for Duchenne Muscular Dystrophy: Lessons Learned from Amino Acid Supplementation in Mouse Models
by: Boel De Paepe
Published: (2023-07-01)

Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the <i>mdx</i> Mouse Model for Duchenne Muscular Dystrophy
by: Jessica R. Terrill, et al.
Published: (2023-02-01)

miR-146a deficiency does not aggravate muscular dystrophy in mdx mice
by: Iwona Bronisz-Budzyńska, et al.
Published: (2019-08-01)

Diminution in sperm quantity and quality in mouse models of Duchenne Muscular Dystrophy induced by a myostatin-based muscle growth-promoting intervention
by: Danielle Vaughan, et al.
Published: (2020-06-01)

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
by: Michael Ogundele, et al.
Published: (2021-08-01)

Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy
by: Cara A. Timpani, et al.
Published: (2017-05-01)

Social stress is lethal in the mdx model of Duchenne muscular dystrophy
by: Maria Razzoli, et al.
Published: (2020-05-01)

Indices of Defective Autophagy in Whole Muscle and Lysosome Enriched Fractions From Aged D2-mdx Mice
by: Swathy Krishna, et al.
Published: (2021-07-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy
by: Amel Saoudi, et al.
Published: (2021-09-01)

Skeletal muscle homeostasis in Duchenne muscular dystrophy: modulating autophagy as a promising therapeutic strategy
by: Clara eDe Palma, et al.
Published: (2014-07-01)

Caveolin-1, caveolin-3 and VEGF expression in the masticatory muscles of mdx mice
by: Alexander Spassov, et al.
Published: (2011-07-01)

Characterization of Alzheimer's disease‐like neuropathology in Duchenne's muscular dystrophy using the DBA/2J mdx mouse model
by: Grant C. Hayward, et al.
Published: (2022-01-01)

Orthopaedic Management in Duchenne Muscular Dystrophy
by: Uma Balachandran, BA, et al.
Published: (2025-02-01)

A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01)

Use of EP3533-Enhanced Magnetic Resonance Imaging as a Measure of Disease Progression in Skeletal Muscle of mdx Mice
by: Alexander Peter Murphy, et al.
Published: (2021-06-01)

Extrajunctional resting Ca2+ influx is not increased in a severely dystrophic expiratory muscle (triangularis sterni) of the mdx mouse
by: C.George Carlson, et al.
Published: (2003-11-01)

Glucocorticoids for Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2013-07-01)

Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle
by: William J. Valentine, et al.
Published: (2022-01-01)

Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy
by: Azeez Aranmolate, et al.
Published: (2017-08-01)

Expression Analysis in Multiple Muscle Groups and Serum Reveals Complexity in the MicroRNA Transcriptome of the mdx Mouse with Implications for Therapy
by: Thomas C Roberts, et al.
Published: (2012-01-01)

The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo
by: Bodvael Fraysse, et al.
Published: (2004-11-01)

Resveratrol Promotes Hypertrophy in Wildtype Skeletal Muscle and Reduces Muscle Necrosis and Gene Expression of Inflammatory Markers in <i>Mdx</i> Mice
by: Keryn G. Woodman, et al.
Published: (2021-02-01)

The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse
by: Aiping Zhang, et al.
Published: (2015-01-01)

Altered visual processing in the mdx52 mouse model of Duchenne muscular dystrophy
by: Mirella Telles Salgueiro Barboni, et al.
Published: (2021-05-01)

Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995-02-01)